Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells

被引:293
作者
Smith, Joshua E.
Medley, Colin D.
Tang, Zhiwen
Shangguan, Dihua
Lofton, Charles
Tan, Weihong [1 ]
机构
[1] Univ Florida, Dept Chem, Ctr Res Bio Nano Interface, Gainesville, FL 32611 USA
[2] Univ Florida, Shands Canc Ctr, UF Genet Inst, Gainesville, FL 32611 USA
[3] Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA
关键词
D O I
10.1021/ac062151b
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
We have extended the use the aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells. The aptamers were selected using a cell-based SELEX strategy in our laboratory for cancer cells that, when utilized in this method, allow for the selective recognition of the cells from complex mixtures including fetal bovine serum samples. Aptamer-conjugated magnetic nanoparticles were used for the selective targeting cell extraction, and aptamer-conjugated fluorescent nanoparticles were employed for sensitive cellular detection. Employing both types of nanoparticles allows for selective and sensitive detection not possible by using the particles separately. Fluorescent nanoparticles amplify the signal intensity versus a single fluorophore label resulting in improved sensitivity. In addition, aptamer-conjugated magnetic nanoparticles allow for extraction and enrichment of target cells not possible with other separation methods. Fluorescent imaging and a microplate reader were used for cellular detection to demonstrate the wide applicability of this methodology for medical diagnostics and cell enrichment and separation.
引用
收藏
页码:3075 / 3082
页数:8
相关论文
共 36 条
[1]   Bioconjugated luminescent nanoparticles for biological applications [J].
Bagwe, RP ;
Zhao, XJ ;
Tan, WH .
JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY, 2003, 24 (3-4) :453-464
[2]  
Belov L, 2001, CANCER RES, V61, P4483
[3]  
Benez A, 1999, J CLIN LAB ANAL, V13, P229, DOI 10.1002/(SICI)1098-2825(1999)13:5<229::AID-JCLA7>3.3.CO
[4]  
2-P
[5]  
Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5
[6]   A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment [J].
Daniels, DA ;
Chen, H ;
Hicke, BJ ;
Swiderek, KM ;
Gold, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (26) :15416-15421
[7]   INVITRO SELECTION OF RNA MOLECULES THAT BIND SPECIFIC LIGANDS [J].
ELLINGTON, AD ;
SZOSTAK, JW .
NATURE, 1990, 346 (6287) :818-822
[8]   Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia [J].
Faderl, S ;
Kantarjian, HM ;
Talpaz, M ;
Estrov, Z .
BLOOD, 1998, 91 (11) :3995-4019
[9]   Nanopartide-aptamer bioconjugates: A new approach for targeting prostate cancer cells [J].
Farokhzad, OC ;
Jon, SY ;
Khademhosseini, A ;
Tran, TNT ;
LaVan, DA ;
Langer, R .
CANCER RESEARCH, 2004, 64 (21) :7668-7672
[10]   Aptamers as ligands in affinity probe capillary electrophoresis [J].
German, I ;
Buchanan, DD ;
Kennedy, RT .
ANALYTICAL CHEMISTRY, 1998, 70 (21) :4540-4545